Treatment Guidelines in Vasculitis
- PMID: 35953232
- DOI: 10.1016/j.rdc.2022.03.006
Treatment Guidelines in Vasculitis
Abstract
The vasculitides encompass a group of inflammatory conditions affecting the blood vessels with severe consequences including tissue ischemia, structural abnormalities, such as aneurysms/dissections, and end organ damage. The different forms are commonly classified based on the size of the blood vessel involved as large-vessel, medium-vessel, and small-vessel vasculitis. The American College of Rheumatology/Vasculitis Foundation recently published guidelines on the management of several forms of primary systemic vasculitides. In this review, the recommendations for giant cell arteritis, Takayasu arteritis, polyarteritis nodosa, granulomatosis with polyangiitis, microscopic polyangiitis, and eosinophilic granulomatosis with polyangiitis are discussed. We highlight the key recommendations, aspects where they diverge from other published guidelines, controversies, and areas of uncertainty.
Keywords: Eosinophilic granulomatosis with polyangiitis; Giant cell arteritis; Granulomatosis with polyangiitis; Microscopic polyangiitis; Polyarteritis nodosa; Takayasu arteritis; Treatment Guidelines; Vasculitis.
Copyright © 2022 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure Dr T.A. Kermani has nothing to disclose. Dr K.J. Warrington has received clinical trial support from Kiniksa and Eli Lilly & Co; honoraria from Chemocentryx. Dr A.B. Dua has received honoraria from Chemocentryx, Novartis, and Abbvie.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical